1339. Results for the Supplemental Microbiological Modified Intent-to-Treat (SmMITT) Population of the RESTORE-IMI 1 Trial of Imipenem/Cilastatin/Relebactam (IMI/REL) vs. Imipenem/Cilastatin Plus Colistin (IMI+CST) in Patients with Imipenem-Nonsusceptible (NS) Bacterial Infections

Kaye, Keith ; File, Thomas ; Boucher, Helen W ; Brown, Michelle ; Aggrey, Angela ; Khan, Ireen ; Joeng, Hee-Koung ; Tipping, Robert ; Du, Jiejun ; Young, Katherine ; Butterton, Joan ; Kartsonis, Nicholas A ; Paschke, Amanda

Open forum infectious diseases, 2018-11, Vol.5 (suppl_1), p.S409-S409 [Periódico revisado por pares]

US: Oxford University Press

Texto completo disponível